Year: 2019
Type: review
Abstract: Brown adipose tissue (BAT) thermogenesis is a conserved mechanism to maintain body temperature in mammals. However, since BAT contribution to energy expenditure can represent a relevant modulator of metabolic homeostasis, many studies have focused on the nervous system and endocrine factors that control the activity of this tissue. There is long-established evidence that the counter-regulatory hormone glucagon negatively influences energy balance, enhances satiety, and increases energy expenditure. Despite compelling evidence showing that glucagon has direct action on BAT thermogenesis, recent findings are questioning this conventional attribute of glucagon action. Glucagon like peptide-1 (GLP-1) is an incretin secreted by the intestinal tract which strongly decreases feeding, and, furthermore, improves metabolic parameters associated with obesity and diabetes. Therefore, GLP-1 receptors (GLP-1-R) have emerged as a promising target in the treatment of metabolic disorders. In this short review, we will summarize the latest evidence in this regard, as well as the current therapeutic glucagon- and GLP-1-based approaches to treating obesity.
DOI: 10.3390/ijms20143445
Institutions: Helmholtz Munich, Universidade de Santiago de Compostela, Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition, Center for Research in Molecular Medicine and Chronic Diseases, Centro de Investigación Biomédica en Red, Instituto de Investigación Sanitaria de Santiago, Universidad Complutense de Madrid
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,824
Awards: G5883727912, G6805852329
OpenAlex ID: W2960344041
